INS and cancer: Cancer cells may be more responsive to the mitogenic effect of insulin overexpressing the insulin receptor (IR) and, specifically, IR isoform A. Furthermore, at supraphysiological concentrations (e.g., obesity and hyperinsulinemia compensatory to insulin resistance), insulin can also interact with the IGF1 receptor.